A survey on established and novel strains for probiotic applications

Advances in Probiotic Technology

Volumn , Issue , 2015, Pages 26-44

  Salvetti, Elisa ^a   Torriani, Sandra ^a   Felis, Giovanna E ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85035040835     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (84)

1. http://www.clinicaltrials.gov/.
2. http://probi.se/files/2009/07/L.-paracasei-8700-2-10.pdf.
3. Agustina, R., F.J. Kok, O. van de Rest, U. Fahmida, A. Firmansyah, W. Lukito, E.J. Feskens, E.G. van den Heuvel, R. Albers and I.M. Bovee-Oudenhoven. 2012. Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children. Pediatrics 129: e1155-1164.
4. Arumugam, M., J. Raes, E. Pelletier, D. Le Paslier, T. Yamada, D.R. Mende, G.R. Fernandes, J. Tap, T. Bruls, J.M. Batto, M. Bertalan, N. Borruel, F. Casellas, L. Fernandez, L. Gautier, T. Hansen, M. Hattori, T. Hayashi, M. Kleerebezem, K. Kurokawa, M. Leclerc, F. Levenez, C. Manichanh, H.B. Nielsen, T. Nielsen, N. Pons, J. Poulain, J. Qin, T. Sicheritz-Ponten, S. Tims, D. Torrents, E. Ugarte, E.G. Zoetendal, J. Wang, F. Guarner, O. Pedersen, W.M. de Vos, S. Brunak, J. Dorè, MetaHIT Consortium, M. Antolín, F. Artiguenave, H.M. Blottiere, M. Almeida, C. Brechot, C. Cara, C. Chervaux, A. Cultrone, C. Delorme, G. Denariaz, R. Dervyn, K.U. Foerstner, C. Friss, M. van de Guchte, E. Guedon, F. Haimet, W. Huber, J. van Hylckama-Vlieg, A. Jamet, C. Juste, G. Kaci, J. Knol, O. Lakhdari, S. Layec, K. Le Roux, E. Maguin, A. Mérieux, R. Melo Minardi, C. M'rini, J. Muller, R. Oozeer, J. Parkhill, P. Renault, M. Rescigno, N. Sanchez, S. Sunagawa, A. Torrejon, K. Turner, G. Vandemeulebrouck, E. Varela, Y. Winogradsky, G. Zeller, J. Weissenbach, S.D. Ehrlich and P. Bork. 2011. Enterotypes of the human gut microbiome. Nature 473: 174-180.
5. Campeotto, F., A. Suau, N. Kapel, F. Magne, V. Viallon, L. Ferraris, A.J. Waligora-Dupriet, P. Soulaines, B. Leroux, N. Kalach, C. Dupont and M.J. Butel. 2011. A fermented formula in pre-term infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA. Br. J. Nutr. 22: 1-10.
6. Chang, B.J., S.U. Park, Y.S. Jang, S.H. Ko, N.M. Joo, S.I. Kim, C.H. Kim and D.K. Chang. 2011. Effect of functional yogurt NY-YP901 in improving the trait of metabolic syndrome. Eur. J. Clin. Nutr. 65: 1250-1255.
7. Chassard, C., E. Delmas, P.A. Lawson and A. Bernalier-Donadille. 2008. Bacteroides xylanisolvens sp. nov., a xylan-degrading bacterium isolated from human faeces. Int. J. Syst. Evol. Microbiol. 58: 1008-1013.
8. Chouraqui, J.P., D. Grathwohl, J.M. Labaune, J.M. Hascoet, I. de Montgolfier, M. Leclaire, M. Giarre and P. Steenhout. 2008. Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial. Am. J. Clin. Nutr. 87: 1365-1373.
9. Chuang, L.C., C.S. Huang, L.W. Ou-Yang and S.Y. Lin. 2011. Probiotic Lactobacillus paracasei effect on cariogenic bacterial flora. Clin. Oral Investig. 15: 471-476.
10. Cimperman, L., G. Bayless, K. Best, A. Diligente, B. Mordarski, M. Oster, M. Smith, F. Vatakis, D. Wiese, A. Steiber and J. Katz. 2011. A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. J. Clin. Gastroenterol. 45: 785-789.
11. Coccorullo, P., C. Strisciuglio, M. Martinelli, E. Miele, L. Greco and A. Staiano. 2010. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. J. Pediatr. 157: 598-602.
12. Corrêa, N.B., F.J. Penna, F.M. Lima, J.R. Nicoli and L.A. Filho. 2011. Treatment of acute diarrhea with Saccharomyces boulardii in infants. J. Pediatr. Gastroenterol. Nutr. 53: 497-501.
13. de Vrese, M., H. Kristen, P. Rautenberg, C. Laue and J. Schrezenmeir. 2011. Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity. J. Dairy Res. 78: 396-403.
14. Dommels, Y.E., R.A. Kemperman, Y.E. Zebregs, R.B. Draaisma, A. Jol, D.A. Wolvers, E.E. Vaughan and R. Albers. 2009. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread. Appl. Environ. Microbiol. 75: 6198-6204.
15. Dubey, A.P., K. Rajeshwari, A. Chakravarty and G. Famularo. 2008. Use of VSL[sharp]3 in the treatment of rotavirus diarrhea in children: preliminary results. J. Clin. Gastroenterol. 42: S126-129.
16. Dutta, P., U. Mitra, S. Dutta, K. Rajendran, T.K. Saha and M.K. Chatterjee. 2011. Randomised controlled clinical trial of Lactobacillus sporogenes (Bacillus coagulans), used as probiotic in clinical practice, on acute watery diarrhoea in children. Trop. Med. Int. Health. 16: 555-561.
17. Ehrström, S., K. Daroczy, E. Rylander, C. Samuelsson, U. Johannesson, B. Anzén and C. Påhlson. 2010. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes Infect. 12: 691-699.
18. Ejtahed, H.S., J. Mohtadi-Nia, A. Homayouni-Rad, M. Niafar, M. Asghari-Jafarabadi, V. Mofid and A. Akbarian-Moghari. 2011. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J. Dairy Sci. 94: 3288-3294.
19. Ejtahed, H.S., J. Mohtadi-Nia, A. Homayouni-Rad, M. Niafar, M. Asghari-Jafarabadi and V. Mofid. 2012. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 28: 539-543.
20. Endo, A., Y. Futagawa-Endo, P. Schumann, R. Pukall and L.M. Dicks. 2012. Bifidobacterium reuteri sp. nov., Bifidobacterium callitrichos sp. nov., Bifidobacterium saguini sp. nov., Bifidobacterium stellenboschense sp. nov. and Bifidobacterium biavatii sp. nov. isolated from faeces of common marmoset (Callithrixjacchus) and red-handed tamarin (Saguinusmidas). Syst. Appl. Microbiol. 35: 92-97.
21. Farrow, J.A.E. and M.D. Collins. 1984. DNA base composition, DNA-DNA homology and long-chain fatty acid studies on Streptococcus thermophilus and Streptococcus salivarius. J. Gen. Microbiol. 130: 357-362.
22. Francavilla, R., E. Lionetti, S.P. Castellaneta, A.M. Magistà, G. Maurogiovanni, N. Bucci, A. De Canio, F. Indrio, L. Cavallo, E. Ierardi and V.L. Miniello. 2008. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study. Helicobacter. 13: 127-134.
23. Garrity, G.M., T.G. Lilburn, J.R. Cole, S.H. Harrison, J. Euzéby and B.J. Tindall. 2007a. Taxonomic outline of the Bacteria and Archaea. Release 7.7 March 6, 2007. Part 9- The Bacteria: Phylum "Firmicutes": Class "Bacilli". http://www.taxonomicoutline.org/index.php/toba/article/view/186/218.
24. Garrity, G.M., T.G. Lilburn, J.R. Cole, S.H. Harrison, J. Euzéby and B.J. Tindall. 2007b. Taxonomic outline of the Bacteria and Archaea. Release 7.7 March 6, 2007. Part 9-The Bacteria: Phylum "Actinobacteria": Class "Actinobacteria". http://www.taxonomicoutline.org/index.php/toba/article/view/186/218.
25. Giralt, J., J.P. Regadera, R. Verges, J. Romero, I. de la Fuente, A. Biete, J. Villoria, J.M. Cobo and F. Guarner. 2008. Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int. J. Radiat. Oncol. Biol. Phys. 71: 1213-1219.
26. Gleeson, M., N.C. Bishop, M. Oliveira and P. Tauler. 2011. Daily probiotic's (Lactobacillus casei Shirota) reduction of infection incidence in athletes. Int. J. Sport Nutr. Exerc. Metab. 21: 55-64.
27. Grześkowiak, Ł., M.M. Grönlund, C. Beckmann, S. Salminen, A. von Berg and E. Isolauri. 2012. The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany. Anaerobe 18: 7-13.
28. Guéniche, A., A. Hennino, C. Goujon, K. Dahel, P. Bastien, R. Martin, R. Jourdain and L. Breton. 2006. Improvement of atopic dermatitis skin symptoms by Vitreoscilla filiformis bacterial extract. Eur. J. Dermatol. 16: 380-384.
29. Guéniche, A., B. Knaudt, E. Schuck, T. Volz, P. Bastien, R. Martin, M. Röcken, L. Breton and T. Biedermann. 2008. Effects of nonpathogenic Gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. Br. J. Dermatol. 159: 1357-1363.
30. Hascoët, J.M., C. Hubert, F. Rochat, H. Legagneur, S. Gaga, S. Emady-Azar and P.G. Steenhout. 2011. Effect of formula composition on the development of infant gut microbiota. J. Pediatr. Gastroenterol. Nutr. 52: 756-762.
31. Hatakka, K., M. Mutanen, R. Holma, M. Saxelin and R. Korpela. 2008. Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS administered in capsules is ineffective in lowering serum lipids. J. Am. Coll. Nutr. 27: 441-447.
32. Hong, Y.S., K.S. Hong, M.H. Park, Y.T. Ahn, J.H. Lee, C.S. Huh, J. Lee, I.K. Kim, G.S. Hwang and J.S. Kim. 2011. Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome. J. Clin. Gastroenterol. 45: 415-425.
33. Indrio, F., G. Riezzo, F. Raimondi, M. Bisceglia, A. Filannino, L. Cavallo and R. Francavilla. 2011. Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. Eur. J. Clin. Invest. 41: 417-422.
34. Iniesta, M., D. Herrera, E. Montero, M. Zurbriggen, A.R. Matos, M.J. Marín, M.C. Sánchez-Beltrán, A. Llama-Palacio and M. Sanz. 2012. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial. J. Clin. Periodontol. 39: 736-744.
35. Jeffery, I.B., M.J. Claesson, P.W. O'Toole and F. Shanahan. 2012. Categorization of the gut microbiota: enterotypes or gradients? Nat. Rev. Microbiol. 10: 591-592.
36. Joo, H.M., K.A. Kim, K.S. Myoung, Y.T. Ahn, J.H. Lee, C.S. Huh, M.J. Han and D.H. Kim. 2012. Lactobacillus helveticus HY7801 ameliorates vulvovaginal candidiasis in mice by inhibiting fungal growth and NF-kB activation. Int. Immunopharmacol. 14: 39-46.
37. Keller, M.K. and S. Twetman. 2012a. Acid production in dental plaque after exposure to probiotic bacteria. BMC Oral Health. 12: 44.
38. Keller, M.K., A. Bardow, T. Jensdottir, J. Lykkeaa and S. Twetman. 2012b. Effect of chewing gums containing the probiotic bacterium Lactobacillus reuteri on oral malodour. Acta Odontol. Scand. 70: 246-250.
39. Keller, M.K., P. Hasslöf, G. Dahlén, C. Stecksén-Blicks and S. Twetman. 2012c. Probiotic supplements (Lactobacillus reuteri DSM 17938 and ATCC PTA5289) do not affect regrowth of mutants streptococci after full-mouth disinfection with chlorhexidine: a randomized controlled multicenter trial. Caries Res. 46: 140-146.
40. Koning, C.J., D. Jonkers, H. Smidt, F. Rombouts, H.J. Pennings, E. Wouters E., Stobberingh and R. Stockbrügger. 2010. The effect of a multispecies probiotic on the composition of the faecal microbiota and bowel habits in chronic obstructive pulmonary disease patients treated with antibiotics. Br. J. Nutr. 10: 1452-1460.
41. Kukkonen, A.K., M. Kuitunen, E. Savilahti, A. Pelkonen, P. Malmberg and M. Mäkelä. 2011. Airway inflammation in probiotic-treated children at 5 years. Pediatr. Allergy Immunol. 22: 249-251.
42. Lebeer, S., J. Vanderleyden and S.C. De Keersmaecker. 2008. Genes and molecules of lactobacilli supporting probiotic action. Microbiol. Mol. Biol. Rev. 72: 728-764.
43. Lee, J.H., B. Lee, H.S. Lee, E.A. Bae, H. Lee, Y.T Ahn, K.S. Lim, C.S. Huh and D.H. Kim. 2009a. Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis. Int. J. Colorectal. 24: 231-237.
44. Lee, H., Y.T. Ahn, J.H. Lee, C.S. Huh and D.H. Kim. 2009b. Evaluation of anti-colitic effect of lactic acid bacteria in mice by cDNA microarray analysis. Inflammation 32: 379-386.
45. Lehtoranta, L., M. Söderlund-Venermo, J. Nokso-Koivisto, H. Toivola, K. Blomgren, K. Hatakka, T. Poussa, R. Korpela and A. Pitkäranta. 2012. Human bocavirus in the nasopharynx of otitis-prone children. Int. J. Pediatr. Otorhinolaryngol. 76: 206-211.
46. Ligaarden, S.C., L. Axelsson, K. Naterstad, S. Lydersen and P. G. Farup. 2010. A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial. BMC Gastroenterol. 10: 16.
47. Mandel, D.R., K. Eichas and J. Holmes. 2010. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement. Altern. Med. 10: 1.
48. Matsuda, F., M.I. Chowdhury, A. Saha, T. Asahara, K. Nomoto, A.A. Tarique, T. Ahmed, M. Nishibuchi, A. Cravioto and F. Qadri. 2011. Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age. Vaccine. 28: 1855-1858.
49. Mattarelli, P., C. Bonaparte, B. Pot and B. Biavati. 2008. Proposal to reclassify the three biotypes of Bifidobacterium longum as three subspecies: Bifidobacterium longum subsp. longum subsp. nov., Bifidobacterium longum subsp. infantis comb. nov. and Bifidobacterium longum subsp. suis comb. nov. Int. J. Syst. Evol. Microbiol. 58: 767-772.
50. Matthes, H., T. Krummenerl, M. Giensch, C. Wolff and J. Schulze. 2010. Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement. Altern. Med. 10: 13.
51. Mayanagi, G., M. Kimura, S. Nakaya, H. Hirata, M. Sakamoto, Y. Benno and H. Shimauchi. 2009. Probiotic effects of orally administered Lactobacillus salivarius WB21-containing tablets on periodontopathic bacteria: a double-blinded, placebo-controlled, randomized clinical trial. J. Clin. Periodontol. 36: 506-513.
52. Mohan, R., C. Koebnick, J. Schildt, M. Mueller, M. Radke and M. Blaut. 2008. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr. Res. 64: 418-422.
53. Montalto, M., A. Gallo, V. Curigliano, F. D'Onofrio, L. Santoro, M. Covino, S. Dalvai, A. Gasbarrini and G. Gasbarrini. 2010. Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy-a randomized, double-blind, cross-over, placebo-controlled study. Aliment. Pharmacol. Ther. 32: 209-214.
54. Morisset, M., C. Aubert-Jacquin, P. Soulaines, D.A. Moneret-Vautrin and C. Dupont. 2010. A non-hydrolyzed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy. Eur. J. Clin. Nutr. 65: 175-183.
55. Moroi, M., S. Uchi, K. Nakamura, S. Sato, N. Shimizu, M. Fujii, T. Kumagai, M. Saito, K. Uchiyama, T. Watanabe, H. Yamaguchi, T. Yamamoto, S. Takeuchi and M. Furue. 2011. Beneficial effect of a diet containing heat-killed Lactobacillus paracasei K71 on adult type atopic dermatitis. J. Dermatol. 38: 131-139.
56. Nishimura, I., T. Igarashi, T. Enomoto, Y. Dake, Y. Okuno and A. Obata. 2009. Clinical efficacy of halophilic lactic acid bacterium Tetragenococcus halophilus Th221 from soy sauce moromi for perennial allergic rhinitis. Allergol. Int. 58: 179-185.
57. Oliva, S., G. Di Nardo, F. Ferrari, S. Maliardo, P. Rossi, G. Patrizi, S. Cucchiara and L. Stronati. 2012. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment. Pharmacol. Ther. 35: 327-34.
58. Pérez, N., J.C. Iannicelli, C. Girard-Bosch, S. González, A. Varea, L. Disalvo, M. Apezteguia, J. Pernas, D. Vicentin and R. Cravero. 2010. Effect of probiotic supplementation on immunoglobulins, isoagglutinins and antibody response in children of low socio-economic status. Eur. J. Nutr. 9: 173-179.
59. Rautava, S., E. Kainonen, S. Salminen and E. Isolauri. 2012. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J. Allergy Clin. Immunol. 130: 1355-1360.
60. Rayes, N., T. Pilarski, M. Stockmann, S. Bengmark, P. Neuhaus and D. Seehofer. 2012. Effect of pre-and probiotics on liver regeneration after resection: a randomised, double-blind pilot study. Benef. Microbes. 3: 237-244.
61. Rojas, M.A., J.M. Lozano, M.X. Rojas, V.A. Rodriguez, M.A. Rondon, J.A. Bastidas, L.A. Perez, C. Rojas, O. Ovalle, J.E. Garcia-Harker, M.E. Tamayo, G.C. Ruiz, A. Ballesteros, M.M. Archila and M. Arevalo. 2012. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 130: e1113-1120.
62. Salvetti, E., S. Torriani and G.E. Felis. 2012. The Genus Lactobacillus: A Taxonomic Update. Probiotics & Antimicro. Prot. 4: 217-226.
63. Savino, F., L. Cordisco, V. Tarasco, E. Palumeri, R. Calabrese, R. Oggero, S. Roos and D. Matteuzzi. 2010. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 126: e526-533.
64. Shanahan, F. 2011. Molecular mechanisms of probiotic action: it's all in the strains! Gut. 60: 1026-1027.
65. Shanahan, F., T.D. Dinan, P. Ross and C. Hill. 2012. Probiotic in transition. Clin. Gastroenterol. Hepatol. 10: 1220-1224.
66. Shimauchi, H., G. Mayanagi, S. Nakaya, M. Minamibuchi, Y. Ito, K. Yamaki and H. Hirata. 2008. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study. J. Clin. Periodontol. 35: 897-905.
67. Simakachorn, N., R. Bibiloni, P. Yimyaem, Y. Tongpenyai, W. Varavithaya, D. Grathwohl, G. Reuteler, J.C. Maire, S. Blum, P. Steenhout, J. Benyacoub and E.J. Schiffrin. 2011. Tolerance, safety, and effect on the faecal microbiota of an enteral formula supplemented with pre- and probiotics in critically ill children. J. Pediatr. Gastroenterol. 53: 174-181.
68. Skovbjerg, S., K. Roos, S.E. Holm, E. Grahn Håkansson, F. Nowrouzian, M. Ivarsson, I. Adlerberth and A.E. Wold. 2009. Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch. Dis. Child. 94: 92-98.
69. Soh, S.E., M. Aw, I. Gerez , Y.S. Chong, M. Rauff, Y.P. Ng, H.B. Wong, N. Pai, B.W. Lee and L.P. Shek. 2009. Probiotic supplementation in the first 6 months of life in at risk Asian infants-effects on eczema and atopic sensitization at the age of 1 year. Clin. Exp. Allergy 39: 571-578.
70. Søndergaard, B., J. Olsson, K. Ohlson, U. Svensson, P. Bytzer and R. Ekesbo. 2011. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial. Scand. J. Gastroenterol. 46: 663-672.
71. Stephens, J.H. and P.J. Hewett. 2012. Clinical trial assessing VSL#3 for the treatment of anterior resection syndrome. ANZ. J. Surg. 82: 420-427.
72. Surono, I.S., F.P. Koestomo, N. Novitasari, F.R. Zakaria, Yulianasari and Koesnandar. 2011. Novel probiotic Enterococcus faecium IS-27526 supplementation increased total salivary sIgA level and bodyweight of pre-school children: a pilot study. Anaerobe 17: 496-500.
73. Sybesma, W., D. Molenaar, W. van IJcken, K. Venema and R. Kort. 2013. Genome instability in Lactobacillus rhamnosus GG. Appl. Environ. Microbiol. 79: 2233-2239.
74. Szajewska, H., E. Gyrczuk and A. Horvath. 2013. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J. Pediatr. 162: 257-262.
75. Taverniti, V. and S. Guglielmetti. 2011. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr. 6: 261-274.
76. Ulsemer, P., K. Toutounian, J. Schmidt, U. Karsten and S. Goletz. 2012a. Preliminary safety evaluation of a new Bacteroides xylanisolvens isolate. Appl. Environ. Microbiol. 78: 528-535.
77. Ulsemer, P., K. Toutounian, G. Kressel, J. Schmidt, U. Karsten, A. Hahn and S. Goletz. 2012b. Safety and tolerance of Bacteroides xylanisolvens DSM 23964 in healthy adults. Benef. Microbes. 3: 99-111.
78. Ulsemer, P., K. Toutounian, J. Schmidt, J. Leuschner, U. Karsten and S. Goletz. 2012c. Safety assessment of the commensal strain Bacteroides xylanisolvens DSM 23964. Regul. Toxicol. Pharmacol. 62: 336-346.
79. van Loveren, H., Y. Sanz and S. Salminen. 2012. Health Claims in Europe: Probiotics and Prebiotics as Case Examples. Annu. Rev. Food. Sci. Technol. 3: 247-261.
80. Vejborg, R.M., C. Friis, V. Hancock, M.A. Schembri and P. Klemm. 2010. A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972. Mol. Genet. Genomics 283: 469-484.
81. Ventura, M., S. O'Flaherty, M.J. Claesson, F. Turroni, T.R. Klaenhammer, D. van Sinderen and P.W. O'Toole. 2009. Genome-scale analysis of health-promoting bacteria: probiogenomics. Nat. Rev. Microbiol. 7: 61-71.
82. Ventura, M., F. Turroni and D. van Sinderen. 2012. Probiogenomics as a tool to obtain genetic insights into adaptation of probiotic bacteria to the human gut. Bioeng. Bugs. 3: 73-79.
83. Wanke, M. and H. Szajewska. 2012. Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, double-blind, placebo-controlled trial. J. Pediatr. 161: 40-43.
84. West, C.E., M.L. Hammarström and O. Hernell. 2009. Probiotics during weaning reduce the incidence of eczema. Pediatr. Allergy Immunol. 20: 430-437.